Polypharmacy reduction in patients treated for chronic diseases
- Conditions
- Patients with chronic diseases and polypharmacy (= 5 prescribed long-term drugs)Not Applicable
- Registration Number
- ISRCTN42003273
- Lead Sponsor
- German Federal Ministry of Education and Research (BMBF) (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1626
Two local hospitals will recruit patients with chronic diseases and polypharmacy meeting the following inclusion criteria:
1. Aged 60+ years
2. Taking = 5 prescribed long-term drugs
3. Likely to spend at least one week in the hospital
1. Inability to take their medication by themselves
2. Inability to give informed consent (e.g. due to dementia)
3. Severe language difficulties
4. Diseases that usually make poly-pharmacotherapy unavoidable (e.g. active malignoma, acquired immunodeficiencies [HIV], hemodialysis)
5. Presumed life expectancy of less than 12 months
Added 20/01/2017:
6. Patients being diagnosed with any type of cancer after recruitment will be excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method